15,300 Shares in Teladoc Inc (TDOC) Purchased by Hodges Capital Management Inc.
Hodges Capital Management Inc. purchased a new stake in Teladoc Inc (NYSE:TDOC) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 15,300 shares of the health services provider’s stock, valued at approximately $533,000.
Other institutional investors have also added to or reduced their stakes in the company. Bank of New York Mellon Corp raised its stake in Teladoc by 2.3% in the third quarter. Bank of New York Mellon Corp now owns 285,788 shares of the health services provider’s stock valued at $9,474,000 after buying an additional 6,396 shares during the last quarter. Goldman Sachs Group Inc. raised its stake in Teladoc by 503.9% in the second quarter. Goldman Sachs Group Inc. now owns 382,167 shares of the health services provider’s stock valued at $13,261,000 after buying an additional 318,880 shares during the last quarter. Janus Henderson Group PLC purchased a new stake in Teladoc in the second quarter valued at about $58,287,000. JPMorgan Chase & Co. raised its stake in Teladoc by 24.4% in the third quarter. JPMorgan Chase & Co. now owns 3,313,729 shares of the health services provider’s stock valued at $108,193,000 after buying an additional 650,129 shares during the last quarter. Finally, New York State Common Retirement Fund raised its stake in Teladoc by 33.2% in the third quarter. New York State Common Retirement Fund now owns 90,513 shares of the health services provider’s stock valued at $3,001,000 after buying an additional 22,554 shares during the last quarter.
TDOC has been the subject of a number of research analyst reports. SunTrust Banks reiterated a “buy” rating and issued a $40.00 price target on shares of Teladoc in a research note on Friday, November 3rd. Deutsche Bank initiated coverage on Teladoc in a research note on Friday, December 8th. They issued a “buy” rating and a $39.00 price target for the company. Canaccord Genuity set a $42.00 price target on Teladoc and gave the company a “buy” rating in a research note on Friday, November 17th. BidaskClub cut Teladoc from a “hold” rating to a “sell” rating in a research note on Wednesday, November 15th. Finally, Zacks Investment Research cut Teladoc from a “buy” rating to a “hold” rating in a research note on Wednesday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $39.43.
Teladoc Inc (NYSE TDOC) opened at $32.95 on Friday. Teladoc Inc has a 12 month low of $19.60 and a 12 month high of $38.40. The stock has a market capitalization of $1,885.48, a PE ratio of -22.88 and a beta of 0.49. The company has a quick ratio of 5.08, a current ratio of 5.08 and a debt-to-equity ratio of 0.83.
COPYRIGHT VIOLATION NOTICE: This report was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/15300-shares-in-teladoc-inc-tdoc-purchased-by-hodges-capital-management-inc/1857609.html.
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Inc (NYSE:TDOC).
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.